AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer

We summarize the available data about the clinical and economic effectiveness of magnetic resonance imaging in the diagnosis and management of prostate cancer, and provide practical recommendations for its use in the screening, diagnosis, staging and surveillance of prostate cancer. A panel of clini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of urology Jg. 198; H. 4; S. 832
Hauptverfasser: Fulgham, Pat F, Rukstalis, Daniel B, Turkbey, Ismail Baris, Rubenstein, Jonathan N, Taneja, Samir, Carroll, Peter R, Pinto, Peter A, Bjurlin, Marc A, Eggener, Scott
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.10.2017
Schlagworte:
Consensus
Cost-Benefit Analysis
Early Detection of Cancer - economics
Early Detection of Cancer - methods
Early Detection of Cancer - standards
Feasibility Studies
Humans
Image-Guided Biopsy - economics
Image-Guided Biopsy - methods
Image-Guided Biopsy - standards
Magnetic Resonance Imaging - economics
Magnetic Resonance Imaging - methods
Magnetic Resonance Imaging - standards
Male
Mass Screening - economics
Mass Screening - methods
Mass Screening - standards
Neoplasm Staging - economics
Neoplasm Staging - methods
Neoplasm Staging - standards
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - economics
Prostatic Neoplasms - pathology
Societies, Medical - standards
Ultrasonography, Interventional - methods
Ultrasonography, Interventional - standards
Urology - methods
Urology - standards
magnetic resonance imaging
early detection of cancer
image-guided biopsy
prostatic neoplasms
ISSN:1527-3792, 1527-3792
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We summarize the available data about the clinical and economic effectiveness of magnetic resonance imaging in the diagnosis and management of prostate cancer, and provide practical recommendations for its use in the screening, diagnosis, staging and surveillance of prostate cancer. A panel of clinicians with expertise in the diagnosis and management of prostate cancer evaluated the current published literature on the use and effectiveness of magnetic resonance imaging for this disease. When adequate studies were available for analysis, recommendations were made on the basis of data and when adequate studies were not available, recommendations were made on the basis of expert consensus. At this time the data support the use of magnetic resonance imaging in patients with a previous negative biopsy and ongoing concerns about increased risk of prostate cancer. The data regarding its usefulness for initial biopsy suggest a possible role for magnetic resonance imaging in some circumstances. There is currently insufficient evidence to recommend magnetic resonance imaging for screening, staging or surveillance of prostate cancer. Although it adds cost to the management of prostate cancer, magnetic resonance imaging offers superior anatomic detail, and the ability to evaluate cellular density based on water diffusion and blood flow based on contrast enhancement. Imaging targeted biopsy may increase the diagnosis of clinically significant cancers by identifying specific lesions not visible on conventional ultrasound. The clinical indications for the use of magnetic resonance imaging in the management of prostate cancer are rapidly evolving.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1527-3792
1527-3792
DOI:10.1016/j.juro.2017.04.101